Trial Profile
Effect of risedronic acid on cortical bone microarchitecture in postmenopausal women with osteopenia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary)
- Indications Bone resorption; Postmenopausal osteoporosis
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.